Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
Wilton B. Williams,R. Ryan Meyerhoff,R.J. Edwards,Hui Li,Kartik Manne,Nathan I. Nicely,Rory Henderson,Ye Zhou,Katarzyna Janowska,Katayoun Mansouri,Sophie Gobeil,Tyler Evangelous,Bhavna Hora,Madison Berry,A. Yousef Abuahmad,Jordan Sprenz,Margaret Deyton,Victoria Stalls,Megan Kopp,Allen L. Hsu,Mario J. Borgnia,Guillaume B.E. Stewart-Jones,Matthew S. Lee,Naomi Bronkema,M. Anthony Moody,Kevin Wiehe,Todd Bradley,S. Munir Alam,Robert J. Parks,Andrew Foulger,Thomas Oguin,Gregory D. Sempowski,Mattia Bonsignori,Celia C. LaBranche,David C. Montefiori,Michael Seaman,Sampa Santra,John Perfect,Joseph R. Francica,Geoffrey M. Lynn,Baptiste Aussedat,William E. Walkowicz,Richard Laga,Garnett Kelsoe,Kevin O. Saunders,Daniela Fera,Peter D. Kwong,Robert A. Seder,Alberto Bartesaghi,George M. Shaw,Priyamvada Acharya,Barton F. Haynes
DOI: https://doi.org/10.1016/j.cell.2021.04.042
IF: 64.5
2021-05-01
Cell
Abstract:Natural antibodies (Abs) can target host glycans on the surface of pathogens. We studied the evolution of glycan-reactive B cells of rhesus macaques and humans using glycosylated HIV-1 envelope (Env) as a model antigen. 2G12 is a broadly neutralizing Ab (bnAb) that targets a conserved glycan patch on Env of geographically diverse HIV-1 strains using a unique heavy-chain (V<sub>H</sub>) domain-swapped architecture that results in fragment antigen-binding (Fab) dimerization. Here, we describe HIV-1 Env Fab-dimerized glycan (FDG)-reactive bnAbs without V<sub>H</sub>-swapped domains from simian-human immunodeficiency virus (SHIV)-infected macaques. FDG Abs also recognized cell-surface glycans on diverse pathogens, including yeast and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike. FDG precursors were expanded by glycan-bearing immunogens in macaques and were abundant in HIV-1-naive humans. Moreover, FDG precursors were predominately mutated IgM<sup>+</sup>IgD<sup>+</sup>CD27<sup>+</sup>, thus suggesting that they originated from a pool of antigen-experienced IgM<sup>+</sup> or marginal zone B cells.
cell biology,biochemistry & molecular biology